Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Incyte Corporation
Beijing Biotech
Bristol-Myers Squibb
Pfizer
National Institutes of Health Clinical Center (CC)
Bristol-Myers Squibb
Children's Hospital Medical Center, Cincinnati
CellCentric Ltd.
Daiichi Sankyo
Ohio State University Comprehensive Cancer Center
Boryung Pharmaceutical Co., Ltd
New York Medical College
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Washington University School of Medicine
Kymera Therapeutics, Inc.
Ohio State University Comprehensive Cancer Center
Bio-Path Holdings, Inc.
Daiichi Sankyo
Columbia University
Kyowa Kirin Co., Ltd.
Pfizer
City of Hope Medical Center
Wake Forest University Health Sciences
University Hospital Southampton NHS Foundation Trust
Stanford University
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Stanford University
University of Nebraska
Ruijin Hospital
University of Nebraska
Therapeutic Advances in Childhood Leukemia Consortium
Eastern Cooperative Oncology Group
Asana BioSciences
Massachusetts General Hospital
Alexion Pharmaceuticals, Inc.
Karyopharm Therapeutics Inc
Columbia University
Mayo Clinic
National Institutes of Health Clinical Center (CC)
Northwestern University
TG Therapeutics, Inc.
AbbVie
Aptevo Therapeutics
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Huazhong University of Science and Technology
University of Michigan Rogel Cancer Center
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)